Skip to main content
. Author manuscript; available in PMC: 2022 Jun 30.
Published in final edited form as: Mol Pharm. 2019 Feb 26;16(4):1766–1774. doi: 10.1021/acs.molpharmaceut.9b00144

Figure 1.

Figure 1.

PyRx simulated SRL complexation with cyclodextrin monomers and predicted binding affinity with standard deviation derived from different possible conformations (A). Experimental determination of SRL and β-CD affinity measured by SPR indicates lowest affinity (B).